Repros Therapeutics, Inc. (RPRX)

[dewophile]

I think the size and scope of the trial for the chronic indication is greater than what was expected. I thought on balance agreement for the anemia indication, which is very low hanging fruit, makes today's announcement a net positive, but the market obviously doesn't agree
More than anything I think people are still trying to get their arms around the news and its implications - even BSR doesn't have an alert out yet which is odd